|
Q3 FY2021
As of Mar 31, 2021
|
Q2 FY2021
As of Dec 31, 2020
|
Q1 FY2021
As of Sep 30, 2020
|
Q4 FY2020
As of Jun 30, 2020
|
Q3 FY2020
As of Mar 31, 2020
|
Q2 FY2020
As of Dec 31, 2019
|
Q1 FY2020
As of Sep 30, 2019
|
Q4 FY2019
As of Jun 30, 2019
|
Q3 FY2019
As of Mar 31, 2019
|
Q2 FY2019
As of Dec 31, 2018
|
Q1 FY2019
As of Sep 30, 2018
|
Q4 FY2018
As of Jun 30, 2018
|
Q3 FY2018
As of Mar 31, 2018
|
Q2 FY2018
As of Dec 31, 2017
|
Q1 FY2018
As of Sep 30, 2017
|
Q4 FY2017
As of Jun 30, 2017
|
Q3 FY2017
As of Mar 31, 2017
|
Q1 FY2017
As of Sep 30, 2016
|
Q2 FY2017
As of Dec 31, 2016
|
Q4 FY2016
As of Jun 30, 2016
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets: | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Note payable to related party | ||||||||||||||||||||
| Due to related party | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Stockholders' Deficit: | ||||||||||||||||||||
| Preferred stock, $0.001 par value; 20,000,000 shares authorized; no shares outstanding and outstanding | ||||||||||||||||||||
| Common stock, $0.001 par value; 150,000,000 shares authorized; 58,167,600 and 58,167,600 shares issued and outstanding | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total Stockholders' Deficit | ||||||||||||||||||||
| Total Liabilities and Stockholders' Equity | ||||||||||||||||||||
Loading...
